OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) major shareholder Jennifer Pritzker sold 326,700 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00. Following the completion of the sale, the insider directly owned 6,536,764 shares of the company’s stock, valued at approximately $150,607,042.56. This represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
OrthoPediatrics Trading Down 1.3%
NASDAQ KIDS traded down $0.31 on Tuesday, reaching $23.00. 139,797 shares of the company were exchanged, compared to its average volume of 173,766. The business’s fifty day moving average price is $21.52 and its 200 day moving average price is $18.72. The stock has a market capitalization of $600.53 million, a P/E ratio of -13.69 and a beta of 0.98. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a fifty-two week low of $14.42 and a fifty-two week high of $26.74.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The company had revenue of $70.51 million during the quarter, compared to analysts’ expectations of $68.21 million. Analysts forecast that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.
Analysts Set New Price Targets
View Our Latest Report on OrthoPediatrics
Hedge Funds Weigh In On OrthoPediatrics
Large investors have recently modified their holdings of the business. AIGH Capital Management LLC purchased a new position in shares of OrthoPediatrics during the 2nd quarter worth $5,161,000. Wasatch Advisors LP raised its holdings in OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock valued at $9,865,000 after buying an additional 186,357 shares during the period. Granahan Investment Management LLC raised its holdings in OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after buying an additional 232,760 shares during the period. Roubaix Capital LLC lifted its position in OrthoPediatrics by 23.8% in the first quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock valued at $4,603,000 after buying an additional 55,724 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new position in OrthoPediatrics in the second quarter valued at about $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.
About OrthoPediatrics
OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.
The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.
Featured Stories
- Five stocks we like better than OrthoPediatrics
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
